Sparrow Quantum A/S is a privately held company that develops and commercializes photonic quantum technology components based on research and patents developed in the Niels Bohr Institute Quantum Photonics Lab. The Niels Bohr Institute’s Quantum Photonics Lab, headed by professor Peter Lodahl, is part of the Danish Center for Quantum Innovation, Qubiz, funded by Innovation Fund Denmark –– a national large scale investment in quantum technologies.
Norbite is a biotech research firm focused on converting plastic waste into sustainable products through an innovative insect-based biorefinery. The company's technology integrates biorefinery and vertical farming methods to process plastic waste, yielding larvae that are bio-refined into proteins suitable for food and feed applications. By offering sustainable solutions, Norbite aims to contribute positively to environmental efforts while providing clients with valuable products and services.
Sensius B.V., founded in 2015 and based in Rotterdam, Netherlands, specializes in innovative cancer treatment through deep thermotherapy specifically targeting the head and neck region. As an Erasmus MC spinoff, the company focuses on developing novel hyperthermia techniques to enhance cancer care, providing a promising approach to improve treatment outcomes for patients suffering from tumors in these areas.
Protinhi Therapeutics is a preclinical stage biotechnology company focused on developing antiviral drugs to combat various viral threats, including dengue, Zika, and COVID-19. The company's innovative approach utilizes proprietary technology and compounds that target viral diseases through protease inhibition. This mechanism disrupts the viruses' ability to replicate, providing healthcare providers with a means to effectively control the spread of these infections. By concentrating on significant public health challenges, Protinhi Therapeutics aims to contribute to global efforts in managing and mitigating viral outbreaks.
Qu & Co is a developer of quantum-computational software focused on creating algorithms tailored for optimizing specialty chemicals, pharmaceuticals, and functional materials. The company's team of highly skilled quantum developers collaborates closely with clients and academic advisors to design innovative quantum algorithms and translate them into effective software solutions. Qu & Co's offerings enhance in-house discovery and optimization processes by advancing quantum-computational chemistry methods, seamlessly integrating with existing workflows in chemistry and material science. This enables clients in the pharmaceutical and other industries to conduct complex chemistry and multiphysics simulations on emerging quantum processors.
Ganymed Robotics SAS, a medical device company, focuses on the development of robotics technologies for orthopedic surgeons. It develops a therapeutic device to enhance surgical precision in knee replacement surgery. The company was incorporated in 2018 and is based in Paris, France.
Onward is developing an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools to rehabilitate patients suffering from neurological disorders such as spinal cord injury (SCI).
Limula Biotech is a Swiss company specializing in the design and development of an automated system for manufacturing cell and gene therapies. The company has created a patented platform that enables the distributed production of genetically engineered cells directly at the patient's bedside, utilizing a patient's white blood cell sample. This fully closed bioreactor system minimizes human intervention during the manufacturing process while maintaining control over cell culture parameters. By facilitating on-site production in hospitals, Limula's technology aims to enhance the safety, accessibility, and efficiency of personalized gene therapies, ultimately reducing time, costs, and logistical challenges. Founded in 2018 and based in Lausanne, Switzerland, Limula Biotech is committed to revolutionizing the delivery of ex vivo gene-engineered cell therapies.
Quandela SAS, founded in 2017 and based in Palaiseau, France, specializes in the production of photonic and semiconductor chips designed for quantum computing applications. The company is recognized for its innovative product, E-delight, which serves as a solid-state source of single and highly indistinguishable photons. This technology plays a crucial role in advancing quantum photonics and quantum information research. Quandela's single-photon source device integrates photonics with semiconductor quantum dots, facilitating efficient collection of emitted single photons at high rates. This capability significantly reduces charge noise decoherence and enhances the emission of identical photons, which is vital for the development of advanced quantum technologies, including communication, computation, and sensing. By focusing on the unique properties of quantum light, Quandela contributes to the progress of photon-based quantum computing and communication networks.
Quandela SAS, founded in 2017 and based in Palaiseau, France, specializes in the production of photonic and semiconductor chips designed for quantum computing applications. The company is recognized for its innovative product, E-delight, which serves as a solid-state source of single and highly indistinguishable photons. This technology plays a crucial role in advancing quantum photonics and quantum information research. Quandela's single-photon source device integrates photonics with semiconductor quantum dots, facilitating efficient collection of emitted single photons at high rates. This capability significantly reduces charge noise decoherence and enhances the emission of identical photons, which is vital for the development of advanced quantum technologies, including communication, computation, and sensing. By focusing on the unique properties of quantum light, Quandela contributes to the progress of photon-based quantum computing and communication networks.
Qarnot is a company based in Montrouge, France, founded in 2010, that specializes in providing economical and ecological high-performance computing (HPC) solutions through its innovative Q.rad computing heater. This unique product combines the functionality of an electrical heater with high-performance computing capabilities, utilizing embedded microprocessors to generate heat during computation. Qarnot's computing heaters have undergone three generations of development and are marketed to construction companies for use in new buildings. By integrating computing and heating, Qarnot offers an affordable alternative to traditional data centers, significantly reducing costs associated with infrastructure, maintenance, and cooling. Users can conveniently manage the temperature of these heaters through an embedded thermostat or a smartphone application, enhancing the overall user experience.
Qubit Pharmaceuticals, incorporated in 2020 and based in Paris, France, develops innovative technology aimed at enhancing pharmaceutical drug discovery. The company offers a drug discovery simulation platform that reduces the cost and duration of preclinical drug development. Utilizing proprietary force field models and molecular dynamics calculations, Qubit's platform conducts virtual screening and visualization to identify promising drug candidates. This approach leverages quantum physics to support biopharmaceutical companies in accelerating their research and development efforts.
QuantWare engages in designing, developing, and fabricating hardware to enable quantum computing.
Lumiphase develops novel optical communication chips that are very inexpensive, super compact, and highly efficient.
Avantama is a leading developer of nanomaterials specifically tailored for electronic applications. The company specializes in nanoparticle dispersions and formulations, offering a range of services including joint development, contract licensing, and customized compositions. Avantama's innovative material technologies facilitate the creation of high-quality optical and electronic coatings using established printing and coating techniques. With a production capacity at the multi-ton scale and adherence to high industry standards, Avantama supports various applications such as displays, OLEDs, Quantum Dot Displays, and solution-processed organic photovoltaics. This capability not only enhances product development but also accelerates time-to-market for its clients, positioning Avantama as a preferred partner for future innovations in the electronics sector.
Neurosoft Bioelectronics specializes in the development of soft implantable electrodes designed to interface with the nervous system for diagnosing and treating neurological disorders. Based in Geneva, Switzerland, the company has created next-generation electrodes that are compliant and conformable, addressing the limitations of existing stiff devices. Their flagship product, SOFT ECoG, is a subdural electrode that records from and stimulates the brain's surface, enhancing recording quality and minimizing MRI artifacts. Neurosoft's technology promotes long-term bio-integration, adapting to both static and dynamic mechanics of neural tissue, which can improve therapeutic outcomes for patients and expand the applications of neural interfaces in clinical settings.
Nuclidium’s vision is to address the unmet need to detect and stage cancer more accurately so that treatment options for cancer patients and their long-term survival can be significantly improved.
New Born Solutions is a medical device company that provides non-invasive screening for infant meningitis.
Dracula Technologies SAS specializes in the design and manufacture of organic photovoltaic cells aimed at providing energy autonomy for connected devices. Founded in 2011 and based in Valence, France, the company develops products that enable small electronic devices, such as phones, GPS units, and lamps, to self-recharge using solar energy. Their flagship product, Light As Your Energetic Response (LAYER), is designed to capture various forms of light, both indoors and outdoors, and convert it into usable energy through advanced digital printing techniques. The team consists of approximately 20 members, including a scientific committee and an administrative committee, all dedicated to fostering innovation and collaboration within the company. Dracula Technologies operates as a subsidiary of Ardeje.
Scipio Bioscience is a biotechnology company based in Paris, France, founded in 2017. The company specializes in manufacturing benchtop kits that serve as a sample preparation solution for single-cell studies. These kits are designed for use in sequencing applications within both clinical and basic research, focusing particularly on transcriptomics. By enabling single-cell barcoding in a test tube format, Scipio Bioscience's products facilitate advanced research in single-cell analysis, supporting laboratories in their scientific endeavors.
Novolyze, SAS is a French company that specializes in food safety solutions for the global food processing industry. Established in 2012 and headquartered in Daix, with an additional office in Cambridge, Massachusetts, Novolyze provides a comprehensive range of equipment, including steam pasteurizers, sterilizers, dryers, roasters, extruders, and ovens. The company is also known for its innovative surrogate microorganisms technology, which allows food manufacturers to test the effectiveness of microbial kill steps under real-life conditions. In addition to its equipment offerings, Novolyze provides services in pasteurization, regulatory compliance, and process validation, as well as food microbiology research to a diverse clientele that includes large corporations, small and medium enterprises, public and private research laboratories, and food processing associations. With a strong emphasis on enhancing food safety and quality, Novolyze employs a team of experts, including food microbiologists and process engineers, and operates state-of-the-art facilities in a pharmaceutical-grade environment for research and development.
New Born Solutions is a medical device company that provides non-invasive screening for infant meningitis.
Nagi Bioscience SA, based in Lausanne, Switzerland, specializes in the development and manufacturing of an innovative automated testing device that utilizes Caenorhabditis elegans, a type of microscopic worm, for the assessment of substances in pharmaceutical, chemical, and cosmetic industries. This technology, known as "Organism-on-Chip," integrates in vivo testing with a fully automated in vitro platform for handling, culturing, and analyzing these organisms. Nagi Bioscience's solutions facilitate toxicity testing, drug discovery, and anthelmintic testing, allowing clients to gain insights into the complete biological responses that can only be observed at the organism level. This approach aims to transform traditional methods of evaluating the toxic or beneficial effects of various substances.
Qnami AG manufactures non-invasive sensors. Its products include ProteusQ, non-invasive magnetic imaging microscope; and Quantum Diamond, which includes Quantilevers MX, diamond probes containing a single NV for high resolution magnetic imaging, and NV diamond membranes, ready-to-use diamond with NV centers. Its applications are multiferroic antiferromagnet, antiferromagnetic ram, microwave imaging, magnetic nanomemories, and superconductivity. Qnami AG was founded in 2017 and is based in Basel, Switzerland.
Scrona is all about simplifying micro- and nanotechnology, from the consumer- and industry-perspective. We offer solutions for convenient microscopic visualization and develop an ink-jet related printing technology that will revolutionize micro- and nanofabrication.
Spartha Medical is a medical technology company focused on developing eco-friendly, invisible coatings designed for medical devices and consumer products to mitigate microbial and inflammatory risks. Utilizing natural biopolymers, the company’s innovative coatings possess antibacterial, antiviral, and anti-inflammatory properties, providing an effective solution for infection control. The technology relies on a patented method of supramolecular assembly, enabling precise control over the properties of the coatings based on specific applications. This approach allows for the creation of multifunctional and easy-to-apply surface treatments that help healthcare institutions maintain disease-free environments on medical devices.
Equal1 Laboratories is accelerating the introduction of useful, cost effective quantum computers within a three-year time horizon. The company has developed a disruptive, scalable and cost-effective quantum computing technology, based on a commercially available silicon semiconductor process. Our solution uses nanometer-scale quantum dots to form qubits on a standard silicon CMOS process. Along with silicon qubits, we have integrated all functions required for a quantum processing unit (QPU) – the brain of the quantum computer – which operates at 3 kelvin with over 10 million transistors. This is the first integrated quantum processing unit of its kind.
Equal1 Laboratories is accelerating the introduction of useful, cost effective quantum computers within a three-year time horizon. The company has developed a disruptive, scalable and cost-effective quantum computing technology, based on a commercially available silicon semiconductor process. Our solution uses nanometer-scale quantum dots to form qubits on a standard silicon CMOS process. Along with silicon qubits, we have integrated all functions required for a quantum processing unit (QPU) – the brain of the quantum computer – which operates at 3 kelvin with over 10 million transistors. This is the first integrated quantum processing unit of its kind.
Xsensio develops the unique Lab-on-Skin™ sensing platform to sense in real-time biochemical information at the surface of the skin, providing unprecedented real-time information about our health and wellness, in a simple and non-invasive way.
The Xsensio Lab-on-Skin™ sensing chip relies on a unique, highly-miniaturized sensing platform developed at the Nanolab of the Swiss Federal Institute of Technology. By leveraging semiconductor properties, our sensing platform unleashes a whole new set of possibilities in continuous health monitoring.
Nova Innovation Ltd. is a tidal energy company based in Edinburgh, United Kingdom, with additional offices in Leith, Caernarfon, and Shetland. Founded in 2009, the company specializes in designing, building, operating, and managing tidal energy devices, including underwater turbines that generate clean electricity from tidal, estuarine, and river flows. Nova Innovation is committed to promoting environmental sustainability and reducing reliance on fossil fuels by engaging with local supply chains, leveraging the expertise of coastal communities. The company gained recognition for deploying the world's first offshore tidal array and has received multiple awards for its contributions to low-carbon innovation. With a rapidly growing team of over 30 employees, Nova Innovation continues to advance its mission of harnessing tidal energy efficiently while ensuring minimal visual impact on marine environments.
EVerZom is a nanomedicine biotech company providing a large scale of GMP manufacturing platform of extracellular vesicles. They develop a bioproduction platform to produce extracellular vesicles at a commercial scale in a GMP compliant way for pharmaceutical companies with applications in regenerative medicine and drug delivery. Extracellular vesicles that encompass exosomes, microvesicles, and apoptotic bodies are the tools used by cells to communicate with each other. EVerZom was founded in 2019 and is headquartered in Paris, Ile-de-France, France.
Quandela SAS, founded in 2017 and based in Palaiseau, France, specializes in the production of photonic and semiconductor chips designed for quantum computing applications. The company is recognized for its innovative product, E-delight, which serves as a solid-state source of single and highly indistinguishable photons. This technology plays a crucial role in advancing quantum photonics and quantum information research. Quandela's single-photon source device integrates photonics with semiconductor quantum dots, facilitating efficient collection of emitted single photons at high rates. This capability significantly reduces charge noise decoherence and enhances the emission of identical photons, which is vital for the development of advanced quantum technologies, including communication, computation, and sensing. By focusing on the unique properties of quantum light, Quandela contributes to the progress of photon-based quantum computing and communication networks.
N2 Applied is a Norwegian technology company focused on innovative solutions for nitrogen fertilizer production directly on farms. Established in 2010 and headquartered in Oslo, the company has developed a method that allows livestock farmers to convert liquid organic substrates, such as manure and biogas digestate, into fertilizer by extracting nitrogen from the air. This process not only enhances the nitrogen content of the substrate but also mitigates ammonia loss and lowers greenhouse gas emissions. N2 Applied's technology promotes resource efficiency and cost savings for farmers by facilitating local fertilizer production, thus eliminating the need for long supply chains and reliance on fossil-based chemical fertilizers. The company's scalable system contributes to a circular farming model, offering additional benefits such as reductions in methane and ammonia emissions, as well as minimizing odors. N2 Applied operates a test center in Norway and has branches in the Netherlands and the UK, positioning itself within the realms of livestock farming, organic agriculture, and sustainable practices.
Developer of a sustainable cooling and heating technology based on magnetic materials designed to replace standard gas compression cooling. The company's technology offers magnetic cooling systems for room temperature applications and hydrogen liquefaction plants, enabling clients to update the standard gas compression cycle with a magnetic refrigeration cycle.
Palobiofarma S.L. is a biotechnology company based in Barcelona, Spain, with an additional facility in Navarra. Founded in 2005, the company specializes in the discovery and development of new drugs that target adenosine receptors, with a focus on treating advanced prostate cancer. By leveraging medicinal chemistry and in vitro pharmacology, Palobiofarma aims to be the first European company to market a selective adenosine receptor modulator, addressing significant medical needs through innovative therapeutic approaches.
Magment is a company that specializes in developing innovative magnetizable concrete materials made from cement and recycled magnetic particles. Founded in 2015, Magment focuses on creating advanced concrete solutions designed to enhance energy transfer for electromagnetic applications. The company aims to revolutionize electric vehicle (EV) charging infrastructure through wireless inductive charging systems, allowing vehicles to charge while in motion or parked. Magment’s products are characterized by their robustness, cost-effectiveness, and global availability, facilitating emission-free transportation. With a strong emphasis on continuous research and development, Magment leverages its extensive expertise in magnetic materials to deliver competitive and customer-oriented solutions for the evolving EV market.
Simplicity Works develops its patented technology 3D Bonding - the simplest method for joining pieces.
Palobiofarma S.L. is a biotechnology company based in Barcelona, Spain, with an additional facility in Navarra. Founded in 2005, the company specializes in the discovery and development of new drugs that target adenosine receptors, with a focus on treating advanced prostate cancer. By leveraging medicinal chemistry and in vitro pharmacology, Palobiofarma aims to be the first European company to market a selective adenosine receptor modulator, addressing significant medical needs through innovative therapeutic approaches.
NanoVation specializes in developing monitoring solutions for patients with chronic respiratory diseases, particularly focusing on conditions like chronic obstructive pulmonary disease (COPD) and asthma. The company has created a nanosensor-based wearable device that detects subtle changes in a patient's respiratory condition, allowing for early identification and intervention at home. This proactive approach aims to improve patient outcomes by enabling healthcare professionals to address respiratory deteriorations before they reach critical stages, thereby reducing the risk of exacerbations and unnecessary hospitalizations. Founded by Gregory Shuster, NanoVation is committed to enhancing the management of chronic respiratory conditions through innovative technology.
Sensius B.V., founded in 2015 and based in Rotterdam, Netherlands, specializes in innovative cancer treatment through deep thermotherapy specifically targeting the head and neck region. As an Erasmus MC spinoff, the company focuses on developing novel hyperthermia techniques to enhance cancer care, providing a promising approach to improve treatment outcomes for patients suffering from tumors in these areas.
Qubit Pharmaceuticals, incorporated in 2020 and based in Paris, France, develops innovative technology aimed at enhancing pharmaceutical drug discovery. The company offers a drug discovery simulation platform that reduces the cost and duration of preclinical drug development. Utilizing proprietary force field models and molecular dynamics calculations, Qubit's platform conducts virtual screening and visualization to identify promising drug candidates. This approach leverages quantum physics to support biopharmaceutical companies in accelerating their research and development efforts.
Roka Furadada mission is to reduce the incidence of skin cancer through research, development, and production of active ingredients and medical devices, with high efficiency and low toxicologic and environmental impact.
Delmic B.V., based in Delft, the Netherlands, specializes in manufacturing correlative light and electron microscopy solutions aimed at advancing life and materials science research. The company’s primary products include SECOM, which integrates fluorescence and electron microscopy; SPARC, a high-performance cathodoluminescence detection system; and Delphi, a combined fluorescence and scanning electron microscope. Delmic also develops software designed to facilitate navigation within its integrated microscopy systems. Founded in 2010, the company is committed to providing effective and user-friendly tools that enhance research capabilities, enabling researchers and organizations to gain insights more efficiently.
Non Equity Assistance in 2021
Sparrow Quantum A/S is a privately held company that develops and commercializes photonic quantum technology components based on research and patents developed in the Niels Bohr Institute Quantum Photonics Lab. The Niels Bohr Institute’s Quantum Photonics Lab, headed by professor Peter Lodahl, is part of the Danish Center for Quantum Innovation, Qubiz, funded by Innovation Fund Denmark –– a national large scale investment in quantum technologies.
Developer of parallel dispensing technology designed to reduce material consumption in the PV (Photovoltaics ) industry. The company's technology is used to apply front metal contacts onto solar cells and can be integrated into conventional production lines for silicon solar cells, replacing the screen printing process normally used for the front-side metal contacts, enabling clients to save resources, increasing the electricity yield and increasing throughput.
NIL Technology ApS is a nanotechnology company based in Kongens Lyngby, Denmark, with a branch in Gothenburg, Sweden. Established in 2006, the company specializes in the optical design, prototyping, and mass production of optical components. NIL Technology offers nanostructured masters for various replication technologies, such as nanoimprint, UV-replication, hot embossing, roll printing, and injection molding. Its product range includes diffractive optical elements, microlens arrays, beam splitters, optical diffusers, and waveguides for augmented and mixed reality applications. The company's solutions cater to diverse sectors, including biotechnology, renewable energy, consumer product packaging, and advanced imaging technologies. By focusing on optical applications for sensors, 3D displays, and smartphones, NIL Technology aims to enable innovative optical solutions for a variety of high-tech industries.
Omnix Medical is dedicated to the development and commercialization of highly effective antibiotic agents against resistant pathogenic bacterial strains. Omnix is addressing an enormous and rapidly growing threat to public health, represented by millions worldwide, who suffer from infections associated with resistant bacteria. Omnix’s technology will tilt the odds in the battle against resistant bacteria and improve the lives of many people worldwide.
We build control hardware for quantum computers. Quantum computers will revolutionize the way we compute by embedding the laws of quantum mechanics in their fundamental building blocks (qubits). To get from the current proof-of-principle prototype quantum computers to earth-shattering computation power, many scientific and engineering challenges have to be solved. Our company has the mission to build the control hardware stacks that can manage the upcoming generations of quantum processors.
NEOS Surgery S.L. is a Barcelona-based company specializing in the research, design, development, and commercialization of implantable medical devices for neurosurgery. Founded in 2003, NEOS focuses on innovative solutions for cranial and spinal surgical applications, including its proprietary BHID cranial fixation system, which is designed for placement in the burr hole of a craniotomy. The company is committed to meeting the needs of neurosurgeons and patients, ensuring its products are both effective and compliant with stringent quality standards, including ISO certifications. By capturing market demands, NEOS aims to create high-value medical devices that enhance surgical outcomes and contribute to advancements in the neurosurgery field.
UniSieve Ltd develops and manufactures mechanically flexible molecular sieving membranes. The company’s technology enables a combination of various molecular sieves and polymeric membranes, yielding reliable separation solutions. It offers its solutions for chemical feedstock purification, biogas upgrading, sensing, space related applications, gas separation, and liquid separation. UniSieve Ltd is based in Zurich, Switzerland.
Deep Branch Biotechnology Ltd., founded in 2018 and based in Nottingham, United Kingdom, with additional offices in the Netherlands, specializes in carbon recycling services. The company has developed scalable technology that converts carbon dioxide from industrial waste gas into clean, nutritious, and sustainable single-cell protein. This innovative process not only helps to reduce the carbon footprint of polluting industries but also offers sustainable alternatives to traditional feed sources such as soy and fishmeal. By transforming emissions into valuable protein, Deep Branch Biotechnology aims to contribute to a more sustainable future in the feed industry.
We build control hardware for quantum computers. Quantum computers will revolutionize the way we compute by embedding the laws of quantum mechanics in their fundamental building blocks (qubits). To get from the current proof-of-principle prototype quantum computers to earth-shattering computation power, many scientific and engineering challenges have to be solved. Our company has the mission to build the control hardware stacks that can manage the upcoming generations of quantum processors.
We build control hardware for quantum computers. Quantum computers will revolutionize the way we compute by embedding the laws of quantum mechanics in their fundamental building blocks (qubits). To get from the current proof-of-principle prototype quantum computers to earth-shattering computation power, many scientific and engineering challenges have to be solved. Our company has the mission to build the control hardware stacks that can manage the upcoming generations of quantum processors.
HIL Applied Medical is developing a new class of ultra-compact, high-performance accelerators for proton therapy. HIL applies a patented approach to particle acceleration and beam delivery, combining nano-technology with ultra-high-intensity lasers and ultra-fast magnets. These technological breakthroughs enable meaningful reduction in the size, complexity and cost of proton therapy systems, without compromising clinical utility. Thus HIL aims to enable, for the first time, a single-room add-on proton therapy solution that is truly cost-effective. HIL Applied Medical is a privately-held company, backed by VCs and global strategic partners. It is headquartered in the High-Tech Park, Givat Ram, Jerusalem, Israel; and have a wholly-owned subsidiary in Reno, Nevada (United States).
Developer of non-invasive inhalers designed for the treatment of respiratory disorders. The company's device generates proprietary pressure pulses that travel into the lung which propagate faster inside the airways than in the surrounding parenchyma, creating multiple momentary dilating forces that gently pry open the collapsed airways, enabling doctors to treat chronic obstructive pulmonary disease by smoothing and spreading the mucus lining layer on the airways walls, which assists in airway clearance and reduces the tendency of airways to re-close.
Omnix Medical is dedicated to the development and commercialization of highly effective antibiotic agents against resistant pathogenic bacterial strains. Omnix is addressing an enormous and rapidly growing threat to public health, represented by millions worldwide, who suffer from infections associated with resistant bacteria. Omnix’s technology will tilt the odds in the battle against resistant bacteria and improve the lives of many people worldwide.
HIL Applied Medical is developing a new class of ultra-compact, high-performance accelerators for proton therapy. HIL applies a patented approach to particle acceleration and beam delivery, combining nano-technology with ultra-high-intensity lasers and ultra-fast magnets. These technological breakthroughs enable meaningful reduction in the size, complexity and cost of proton therapy systems, without compromising clinical utility. Thus HIL aims to enable, for the first time, a single-room add-on proton therapy solution that is truly cost-effective. HIL Applied Medical is a privately-held company, backed by VCs and global strategic partners. It is headquartered in the High-Tech Park, Givat Ram, Jerusalem, Israel; and have a wholly-owned subsidiary in Reno, Nevada (United States).
Developer of non-invasive inhalers designed for the treatment of respiratory disorders. The company's device generates proprietary pressure pulses that travel into the lung which propagate faster inside the airways than in the surrounding parenchyma, creating multiple momentary dilating forces that gently pry open the collapsed airways, enabling doctors to treat chronic obstructive pulmonary disease by smoothing and spreading the mucus lining layer on the airways walls, which assists in airway clearance and reduces the tendency of airways to re-close.
Developer of batteryless microcontrollers intended to convert one IoT device at a time to a battery-free ecosystem. The company's wireless microcontrollers are self-powered and battery-free which harvest energy from their surroundings making health information more accessible and easier to interpret by reducing the barrier between people and healthcare technology, enabling individuals to be more confident about their health and spend more time focusing on everything else.
Nanogence SA manufactures novel material solutions for the construction sector. The company develops synthetic tailor-made novel material in a B2B framework in application sectors such as construction, pharmaceutical and mobility. Nanogence SA was founded in 2017 and is based in Renens, Switzerland.
ATLANT 3D Nanosystems is a global pioneer combining unique advanced technologies to enable atomic layer 3D printing. The company was founded in 2018 by Dr. Maksym Plakhotnyuk, Ivan Kundrata, and Prof. Dr. Julien Bachmann with a vision of delivering the first-ever atomic layer 3D printing technology to reshape the future atom by atom. Our state-of-the-art atomic layer 3D printing technology is a true European creation, supported by three major European universities: Technical University of Denmark, Institute of Electrical Engineering Slovak Academy of Sciences, and Friedrich Alexander University Erlangen-Nuremberg.
Neuro Event Labs Oy is a Finnish medical technology company founded in 2015 and based in Tampere. The company specializes in developing artificial intelligence-powered software that monitors epilepsy patients both at home and in clinical settings. Its primary product collects and analyzes accurate data on epilepsy seizures through the use of video and various sensors, leveraging computer vision, smart analytics, and machine learning. This data is relayed to healthcare providers, allowing them to make informed treatment decisions tailored to individual patients. The solution has been crafted in collaboration with leading hospitals in Finland, enhancing its reliability and effectiveness in managing epilepsy care.
Qarnot is a company based in Montrouge, France, founded in 2010, that specializes in providing economical and ecological high-performance computing (HPC) solutions through its innovative Q.rad computing heater. This unique product combines the functionality of an electrical heater with high-performance computing capabilities, utilizing embedded microprocessors to generate heat during computation. Qarnot's computing heaters have undergone three generations of development and are marketed to construction companies for use in new buildings. By integrating computing and heating, Qarnot offers an affordable alternative to traditional data centers, significantly reducing costs associated with infrastructure, maintenance, and cooling. Users can conveniently manage the temperature of these heaters through an embedded thermostat or a smartphone application, enhancing the overall user experience.
Xsensio develops the unique Lab-on-Skin™ sensing platform to sense in real-time biochemical information at the surface of the skin, providing unprecedented real-time information about our health and wellness, in a simple and non-invasive way.
The Xsensio Lab-on-Skin™ sensing chip relies on a unique, highly-miniaturized sensing platform developed at the Nanolab of the Swiss Federal Institute of Technology. By leveraging semiconductor properties, our sensing platform unleashes a whole new set of possibilities in continuous health monitoring.
SOMAprobes S.L. develops healthcare technology for magnetic resonance imaging detection of bacterial pathogens at the onset of infectious disease. The company was incorporated in 2014 and is based in Donostia, Spain.
Xsensio develops the unique Lab-on-Skin™ sensing platform to sense in real-time biochemical information at the surface of the skin, providing unprecedented real-time information about our health and wellness, in a simple and non-invasive way.
The Xsensio Lab-on-Skin™ sensing chip relies on a unique, highly-miniaturized sensing platform developed at the Nanolab of the Swiss Federal Institute of Technology. By leveraging semiconductor properties, our sensing platform unleashes a whole new set of possibilities in continuous health monitoring.
Nimesis SAS develops, manufactures, and markets memory alloys on copper and nickel-titanium in France and internationally. Its products include round or flat wires, thin ribbons, and beta 3 alloys. The company also offers smelting works, transformation, characterization, and engineering and design services to companies. Its products are used in medical, automobile, aerospace, aeronautical, clock industry, jewelery, and Microsystems industrial sectors. The company was founded in 2004 and is based in Metz, France.
Plasmacure, located in Eindhoven, the Netherlands, focuses on developing cold plasma technology aimed at treating chronic wounds, particularly diabetic foot wounds. This innovative approach not only targets and eliminates bacteria but also promotes cell proliferation and enhances microcirculation. By addressing these critical factors, Plasmacure's technology helps healthcare professionals reduce the risk of amputation and improve the overall quality of life for patients suffering from chronic wounds.
Hafnium Labs supports chemicals, energy, and pharma companies by solving one of the biggest challenges in chemistry: Obtaining reliable physical properties fast. From drugs that save our lives, to crop and energy technologies that will save our tomorrow, advances in chemistry change the world. By supporting researchers and engineers working with chemistry we help create a brighter future. We have developed a breakthrough system for combining state-of-the-art predictive methods, such as quantum chemistry and AI, with experimental physical property data. By intelligently and transparently using all available information, we provide the most accurate physical property predictions and quantify the uncertainty, so you know how reliable each prediction is. Our Q-props™ tools support decision making from molecular discovery to process optimization. Check out our website and reach out to learn more about how to use Q-props™ in your company.
Demeta S.A.S develops catalysts for green chemistry. The company offers Olefin Metathesis technology platform, which includes NexTene resins, a ruthenium catalysts; and Polymetallic Catalysis platform for oxidative cleavage of alkenes. The company was incorporated in 2011 and is based in Rennes, France.
NanoVation specializes in developing monitoring solutions for patients with chronic respiratory diseases, particularly focusing on conditions like chronic obstructive pulmonary disease (COPD) and asthma. The company has created a nanosensor-based wearable device that detects subtle changes in a patient's respiratory condition, allowing for early identification and intervention at home. This proactive approach aims to improve patient outcomes by enabling healthcare professionals to address respiratory deteriorations before they reach critical stages, thereby reducing the risk of exacerbations and unnecessary hospitalizations. Founded by Gregory Shuster, NanoVation is committed to enhancing the management of chronic respiratory conditions through innovative technology.
Demeta S.A.S develops catalysts for green chemistry. The company offers Olefin Metathesis technology platform, which includes NexTene resins, a ruthenium catalysts; and Polymetallic Catalysis platform for oxidative cleavage of alkenes. The company was incorporated in 2011 and is based in Rennes, France.
Imaqen Ltd. is a Finnish healthcare technology company developing a new pre-screening solution for early detection of cancer. The innovation offers a non-invasive patient examination and it is suitable for use in wide range of healthcare facilities. The utilised method is protected by patents. Their team consists of experienced diagnostic imaging and clinical research professionals with solid track records in successful product development and global sales and marketing.
Nanoker Research is a SME-company founded in 2011 with the aim to achieve the commercial exploitation of the research results generated in the European Integrated Project IP NANOKER “Structural ceramic nanocomposites for top-end functional applications” (515784. FP6-NMP). This project was focused on the development of several families of a new generation of nanostructured ceramic materials with potential application in different market sectors. Nanoker joined together professionals with more than 20 years of experience in the production and development of technical ceramics with entrepreneurs from academia with a deep knowledge on nanoceramics and nanocomposites. Nanoker Research, S.L. produces and commercializes high performance ceramic components based on advanced ceramics, nanoceramics and nanocomposites for industrial and biomedical applications. Nanoker Research, S.L. focuses its activity in the field of technical ceramics for industrial applications through the trademark Keratec Advanced Materials whereas produces and commercializes biomedical products through the company Bioker Research, S.L.
Nova Fabrica is a manufacturer and worldwide supplier of thin film process components, such as plasma monitoring and control systems, plasma generators and bias power supplies, magnetron sputtering devices, ion and plasma sources. The comprehensive product portfolio allows Nova Fabrica offering a complete package solution with appropriate integration support. Nova Fabrica's directly manufactured specialist products, such as FloTron™ process control systems, are distributed worldwide via a comprehensive sales network.
Created in July 2014, Aenitis Technologies is a French start-up resulting from the work of Mauricio HOYOS and Jean-Luc AIDER, both CNRS researchers at the PMMH Laboratory (Physics and Mechanics of Heterogeneous Media at the ESPCI ParisTech, a research engineer’s school in Paris. The company focuses on medical devices’ area, where their breakthrough technologies are highly promising. Aenitis Technologies is developing innovative separation, manipulation and filtration of biological elements solutions, based on acoustophoresis technologies. The company first focuses on technological solutions that will revolutionize current practices in Public Health. Aenitis Technologies aims to become a world leader in filtering / separating solutions by acoustophoresis.